Lutein and zeaxanthin toxicity with and without brilliant blue in rabbits

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 7, 2014, Pages 559-566

  Furlani, Bruno Albuquerque ^a   Barroso, Letícia ^a   Sousa Martins, Diogo ^a   Maia, Mauricio ^a   Moraes Filho, Milton Nunes ^a   Badaro, Emerson ^a   Portella, Renata ^a   Lima Filho, Acácio Alves ^a   Rodrigues, Eduardo Buchelle ^a   Belfort, Rubens ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; BRILLIANT BLUE; XANTHOPHYLL; ZEAXANTHIN; BENZENESULFONIC ACID DERIVATIVE; COLORING AGENT;

A WAVE; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; B WAVE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DARK ADAPTATION; DRUG SAFETY; ELECTRORETINOGRAPHY; EXPERIMENTAL MODEL; EYE MALFORMATION; FEMALE; HISTOPATHOLOGY; LIGHT; NEW ZEALAND WHITE (RABBIT); NONHUMAN; OSMOLARITY; PH; RETINA MACULA LUTEA; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY; VITREOUS BODY; ANIMAL; DRUG EFFECTS; EYE; INTRAVITREAL DRUG ADMINISTRATION; RABBIT;

ANIMALS; BENZENESULFONATES; COLORING AGENTS; ELECTRORETINOGRAPHY; EYE; FEMALE; INTRAVITREAL INJECTIONS; LUTEIN; RABBITS; ZEAXANTHINS;

EID: 84906965085     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0171     Document Type: Article

References (34)

1. Rodrigues, E.B., Costa, E.F., Penha, F.M., et al. The use of vital dyes in ocular surgery. Surv. Ophthalmol. 54:576-617, 2009.
2. Farah, M.E., Maia, M., and Rodrigues, E.B. Dyes in ocular surgery: principles for use in chromovitrectomy. Am. J. Ophthalmol. 148:332-340, 2009.
3. Gandorfer, A., Messmer, E.M., Ulbig, M.W., and Kampik, A. Indocyanine green selectively stains the internal limiting membrane. Am. J. Ophthalmol. 131:387-388, 2001.
4. Haritoglou, C., Gandorfer, A., Gass, C.A., et al. In-docyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am. J. Ophthalmol. 134: 836-841, 2002.
5. Penha, F.M., Maia, M., Eid Farah, M., et al. Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology. 114:899-908, 2007.
6. Haritoglou, C., Gandorfer, A., and Kampik, A. Indocyanine green-assisted vitreomacular surgery: adverse effects. Graefes Arch. Clin. Exp. Ophthalmol. 241:958, 2003.
7. Iriyama, A., Uchida, S., Yanagi, Y., et al. Effects of in-docyanine green on retinal ganglion cells. IOVS. 45:943-947, 2004.
8. Ho, J.D., Tsai, R.J., Chen, S.N., and Chen, H.C. Cytotoxi-city of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Arch. Ophthalmol. 121:1423-1429, 2003.
9. Tokuda, K., Zorumski, C.F., and Izumi, Y. Involvement of illumination in indocyanine green toxicity after its washout in the ex vivo rat retina. Retina. 29:371-379, 2009.
10. Rezai, K.A., Farrokh-Siar, L., Ernest, J.T., and van Se-venter, G.A. Indocyanine green induces apoptosis in human retinal pigment epithelial cells. Am. J. Ophthalmol. 137: 931-933, 2004.
11. Maia, M., Margalit, E., Lakhanpal, R., et al. Effects of intravitreal indocyanine green injection in rabbits. Retina. 24:69-79, 2004.
12. Maia, M., Kellner, L., de Juan, E., Jr., et al. Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina. 24:80-91, 2004.
13. Narayanan, R., Kenney, M.C., and Kamjoo, S. Toxicity of indocyanine green (ICG) in combination with light on retinal pigment epithelial cells and neurosensory retinal cells. Curr. Eye Res. 30:471-447, 2005.
14. Penha, F.M., Maia, M., Farah, M.E., et al. Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits. J. Ocul. Pharmacol. Ther. 24:52-61, 2008.
15. Rodrigues, E.B., Meyer, C.H., Farah, M.E., and Kroll, P. Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes. Ophthalmologica. 219:251-262, 2005.
16. Wu, W.-C., Hu, D.-N., and Roberts, J.E. Phototoxicity of indocyanine green on human retinal pigment epithelium in vitro and its reduction by lutein. Photochem. Photobiol. 81:537-540, 2005.
17. Enaida, H., and Ishibashi, T. Brilliant blue in vitreoretinal surgery. Dev. Ophthalmol. 42:115-125, 2008.
18. Enaida, H., Hisatomi, T., Hata, Y., et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina. 26:631-636, 2006.
19. Yuen, D., Gonder, J., Proulx, A., Liu, H., and Hutnik, C. Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and in-docyanine green. Am. J. Ophthalmol. 147:251-259, e252, 2009.
20. Yemelyanov, A.Y., Katz, N.B., and Bernstein, P.S. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp. Eye Res. 72:381-392, 2001.
21. Ahmed, S.S., Lott, M.N., and Marcus, D.M. The macular xanthophylls. Surv. Ophthalmol. 50:183-193, 2005.
22. Snodderly, D.M., Handelman, G.J., and Adler, A.J. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest. Ophthalmol. Vis. Sci. 32:268-279, 1991.
23. Gale, C.R., Hall, N.F., Phillips, D.I., and Martyn, C.N. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology. 108:1992-1998, 2001.
24. Sommerburg, O., Keunen, J.E., Bird, A.C., and van Kuijk, F.J. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br. J. Ophthalmol. 82:907-910, 1998.
25. Mares-Perlman, J.A., Brady, W.E., Klein, R., et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch. Ophthalmol. 113:1518-1523, 1995.
26. Nolan, J.M., Stack, J., Mellerio, J., et al. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr. Eye Res. 31:199-213, 2006.
27. Falsini, B., Piccardi, M., Iarossi, G., et al. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electro-physiologic assessment. Ophthalmology. 110:51-60, 2003.
28. Bone, R.A., Landrum, J.T., Mayne, S.T., et al. Macular pigment in donor eyes with and without AMD: a case-control study. Invest. Ophthalmol. Vis. Sci. 42:235-240, 2001.
29. Rodrigues, E.B., Penha, F.M., Furlani, B., et al. Historical aspects and evolution of the application of vital dyes in vitreoretinal surgery and chromovitrectomy. Dev. Oph-thalmol. 42:29-34, 2008.
30. Sousa-Martins, D., Maia, M., Moraes, M., et al. Use of lutein and zeaxanthin alone or combined with brilliant blue to identify intraocular structures intraoperatively. Retina. 32:1328-36, 2012.
31. Enaida, H., Hisatomi, T., Goto, Y., et al. Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina. 26:623-630, 2006.
32. Remy, M., Thaler, S., Schumann, R.G., et al. An in vivo evaluation of Brilliant Blue G in animals and humans. Br. J. Ophthalmol. 92:1142-1147, 2008.
33. Creuzot-Garcher, C., Acar, N., Passemard, M., et al. Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina. Retina. 30:1294-1301, 2010.
34. Rodrigues, E.B., Penha, F.M., Farah, M.E., et al. Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina. 29:497-510, 2009.